1. 1. Hirano K, Ikeda Y, Zaima N, et al. Triglyceride deposit cardiomyovasculopathy. N Engl J Med 2008; 359: 2396-8.
2. 2. Hirano K. A novel clinical entity: triglyceride deposit cardiomyovasculopathy. J Atheroscler Thromb 2009; 16: 702-5.
3. 3. Hirano K, Tanaka T, Ikeda Y, et al. Genetic mutations in adipose triglyceride lipase and myocardial up-regulation of peroxisome proliferated activated receptor-γ in patients with triglyceride deposit cardiomyovasculopathy. Biochem Biophys Res Commun 2014; 443: 574-9.
4. 4. Hara Y, Kawasaki N, Hirano K, et al. Quantitative proteomic analysis of cultured skin fibroblast cells derived from patients with triglyceride deposit cardiomyovasculopathy. Orphanet J Rare Dis 2013; 8: 197.
5. 5. Hirano K, Ikeda Y, Sugimura K, et al. Cardiomyocyte steatosis and defective washout of iodine-123-β-methyl iodophenyl-pentadecanoic acid in genetic deficiency of adipose triglyceride lipase. Eur Heart J 2015; 36: 580.